NCT02648308 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Asselin J, Osunlana AM, Ogunleye AA, Sharma AM, Campbell-Scherer D
Missing an opportunity: the embedded nature of weight management in primary care. Clin Obes. 2015 Dec;5(6):325-32. doi: 10.1111/cob.12115. Epub 2015 Aug 25.
Campbell-Scherer DL, Asselin J, Osunlana AM, Fielding S, Anderson R, Rueda-Clausen CF, Johnson JA, Ogunleye AA, Cave A, Manca D, Sharma AM
Implementation and evaluation of the 5As framework of obesity management in primary care: design of the 5As Team (5AsT) randomized control trial. Implement Sci. 2014 Jun 19;9:78. doi: 10.1186/1748-5908-9-78.
Osunlana AM, Asselin J, Anderson R, Ogunleye AA, Cave A, Sharma AM, Campbell-Scherer DL
5As Team obesity intervention in primary care: development and evaluation of shared decision-making weight management tools. Clin Obes. 2015 Aug;5(4):219-25. doi: 10.1111/cob.12105. Epub 2015 Jun 30.

Extension of the 5As Team Study for Improved Provider Obesity Management to Physicians and Medical Trainees (Part 2)

Clinical trial NCT02648308 - References